2026 BIO International Biotechnology Convention & Exhibition, USA

The 2026 BIO International Convention in the USA is one of the largest and most influential annual events in the global biotechnology sector. Organized by the Biotechnology Innovation Organization (BIO), it has a glorious history of over thirty years since its inception in 1993, rotating annually among major cities in the United States, with San Diego, a significant biotechnology industry hub, often being a preferred venue. This year's convention will be held at the San Diego Convention Center, and is expected to once again bring together top biotechnology companies, large pharmaceutical enterprises, venture capital firms, academic research institutions, and government representatives from around the world to discuss the latest advancements and future trends in biotechnology. The convention content is extremely rich, including not only displays of cutting-edge technologies and innovative products but also hundreds of specialized seminars, keynote speeches, and partnering meetings, covering various sub-fields from drug discovery and development, gene editing, cell therapy to biomanufacturing, and digital health. Attracting thousands of exhibitors and tens of thousands of professional visitors annually, it provides an unparalleled platform for exchange, learning, and business cooperation for all participants, greatly promoting innovation and deep international cooperation in the global biotechnology industry. Its extensive international participation and high-level professional content make it an indispensable annual event for the biotechnology industry, with profound implications for the advancement of the global biopharmaceutical industry and the improvement of human health and well-being.

The exhibit range of the 2026 BIO International Convention in the USA covers all core areas of the biotechnology industry, aiming to comprehensively showcase the latest industry achievements and future development directions. Specific exhibits include but are not limited to: biopharmaceuticals and biologics, such as novel vaccines, gene therapy drugs, cell therapy products, monoclonal antibodies, recombinant protein drugs, biosimilars, etc.; biotechnology tools and equipment, including high-throughput sequencers, mass spectrometers, bioreactors, cell culture systems, laboratory automation equipment, bioinformatics software, and data analysis platforms; diagnostic technologies and products, such as molecular diagnostic kits, in vitro diagnostic equipment, companion diagnostic technologies, biomarker detection platforms; agricultural biotechnology, involving gene-edited crops, biopesticides, biofertilizers, animal vaccines, and feed additives; industrial biotechnology, including biofuels, bio-based materials, industrial enzymes, biorefining technologies; contract research and manufacturing services (CRO/CDMO), providing one-stop services for drug discovery, preclinical research, clinical trials, bioprocess development, and manufacturing; medical devices and digital health solutions, such as wearable biosensors, telemedicine platforms, AI-assisted diagnostic systems, biomedical big data analysis; as well as intellectual property, investment and financing services, policy and regulatory consulting, and other supporting services. In addition, the exhibition will also highlight emerging technologies, such as CRISPR gene editing technology, mRNA vaccine technology, synthetic biology, and the application of artificial intelligence in drug discovery, providing an excellent platform for innovators, investors, and collaborators in the global biotechnology field to understand industry dynamics and seek cooperation opportunities.

No fee information available. Please contact us for a quote.